Furthermore, TMAO was positively correlated with Alzheimer’s disease and with the biomarkers of neuronal degeneration (p-tau, p-tau/AB42, total tau, and neurofilament light chain protein) [121]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.